| Primary |
| Eye Infection |
18.0% |
| Conjunctivitis |
11.7% |
| Eye Inflammation |
8.6% |
| Blepharitis |
7.8% |
| Hypertension |
7.8% |
| Eye Allergy |
6.3% |
| Off Label Use |
4.7% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Dry Eye |
3.9% |
| Hordeolum |
3.9% |
| Chalazion |
3.1% |
| Keratoconjunctivitis Sicca |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Vitamin Supplementation |
3.1% |
| Glaucoma |
2.3% |
| Ocular Hyperaemia |
2.3% |
| Blood Cholesterol Increased |
1.6% |
| Cardiac Disorder |
1.6% |
| Conjunctivitis Bacterial |
1.6% |
| Conjunctivitis Infective |
1.6% |
|
| Ocular Hyperaemia |
13.5% |
| Drug Ineffective |
9.5% |
| Eye Irritation |
8.1% |
| Eyelid Oedema |
8.1% |
| Lacrimation Increased |
6.8% |
| Eye Pain |
5.4% |
| Headache |
5.4% |
| Hypersensitivity |
5.4% |
| Condition Aggravated |
4.1% |
| Drug Hypersensitivity |
4.1% |
| Eye Pruritus |
4.1% |
| Instillation Site Pain |
4.1% |
| Conjunctivitis |
2.7% |
| Intraocular Pressure Increased |
2.7% |
| Medication Error |
2.7% |
| Ocular Discomfort |
2.7% |
| Pharmaceutical Product Complaint |
2.7% |
| Photophobia |
2.7% |
| Rash Pruritic |
2.7% |
| Vision Blurred |
2.7% |
|
| Secondary |
| Eye Infection |
18.4% |
| Off Label Use |
12.3% |
| Blepharitis |
8.8% |
| Eye Inflammation |
7.9% |
| Panic Attack |
6.1% |
| Dry Eye |
5.3% |
| Episcleritis |
5.3% |
| Hypertension |
4.4% |
| Ocular Hyperaemia |
4.4% |
| Hordeolum |
3.5% |
| Lacrimation Increased |
3.5% |
| Dacryostenosis Acquired |
2.6% |
| Depression |
2.6% |
| Eye Pruritus |
2.6% |
| Glaucoma |
2.6% |
| Thyroid Disorder |
2.6% |
| Blood Cholesterol Increased |
1.8% |
| Conjunctivitis |
1.8% |
| Corneal Infiltrates |
1.8% |
| Eye Allergy |
1.8% |
|
| Lacrimation Increased |
19.2% |
| Eye Pruritus |
13.5% |
| Abdominal Pain Upper |
5.8% |
| Dry Eye |
5.8% |
| Eye Irritation |
5.8% |
| Hypersensitivity |
5.8% |
| Myopia |
5.8% |
| Ocular Hyperaemia |
5.8% |
| Eye Pain |
3.8% |
| Eyelid Oedema |
3.8% |
| Headache |
3.8% |
| Oxygen Saturation Decreased |
3.8% |
| Swelling Face |
3.8% |
| Blepharitis |
1.9% |
| Condition Aggravated |
1.9% |
| Drug Ineffective |
1.9% |
| Dysuria |
1.9% |
| Eye Disorder |
1.9% |
| Eyelid Ptosis |
1.9% |
| Instillation Site Pain |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.6% |
| Nasopharyngitis |
9.7% |
| Diabetes Mellitus |
7.8% |
| Asthma |
7.1% |
| Convulsion |
7.1% |
| Gastric Disorder |
7.1% |
| Nervousness |
7.1% |
| Pruritus |
7.1% |
| Rash |
7.1% |
| Sinusitis |
7.1% |
| Pneumonia |
3.9% |
| Drug Use For Unknown Indication |
3.2% |
| Rheumatoid Arthritis |
2.6% |
| Hepatitis C |
1.9% |
| Wheezing |
1.9% |
| Blood Pressure |
1.3% |
| Sjogren's Syndrome |
1.3% |
| Stress Fracture |
1.3% |
| Ankylosing Spondylitis |
0.6% |
| Atrial Fibrillation |
0.6% |
|
| Swelling |
25.0% |
| Weight Decreased |
15.6% |
| Rash Pruritic |
9.4% |
| Bacterial Infection |
3.1% |
| Cerebral Haemorrhage |
3.1% |
| Drug Dose Omission |
3.1% |
| Drug Ineffective |
3.1% |
| Dyspnoea |
3.1% |
| Glaucoma |
3.1% |
| Keratitis |
3.1% |
| Muscle Atrophy |
3.1% |
| Ocular Hyperaemia |
3.1% |
| Post Procedural Complication |
3.1% |
| Skin Tightness |
3.1% |
| Thrombophlebitis Superficial |
3.1% |
| Tremor |
3.1% |
| Vitamin D Deficiency |
3.1% |
| Vitreous Detachment |
3.1% |
| Vulvovaginal Candidiasis |
3.1% |
|
